Patterns of somatic mutation in human cancer genomes

Nature

Volumn 446, Issue 7132, 2007, Pages 153-158

  Greenman, Christopher ^a   Stephens, Philip ^a   Smith, Raffaella ^a   Dalgliesh, Gillian L ^a   Hunter, Christopher ^a   Bignell, Graham ^a   Davies, Helen ^a   Teague, Jon ^a   Butler, Adam ^a   Stevens, Claire ^a   Edkins, Sarah ^a   O'Meara, Sarah ^a   Vastrik, Imre ^b   Schmidt, Esther E ^b   Avis, Tim ^a   Barthorpe, Syd ^a   Bhamra, Gurpreet ^a   Buck, Gemma ^a   Choudhury, Bhudipa ^a   Clements, Jody ^a   Cole, Jennifer ^a   Dicks, Ed ^a   Forbes, Simon ^a   Gray, Kris ^a   Halliday, Kelly ^a   Harrison, Rachel ^a   Hills, Katy ^a   Hinton, Jon ^a   Jenkinson, Andy ^a   Jones, David ^a   Menzies, Andy ^a   Mironenko, Tatiana ^a   Perry, Janet ^a   Raine, Keiran ^a   Richardson, Dave ^a   Shepherd, Rebecca ^a   Small, Alexandra ^a   Tofts, Calli ^a   Varian, Jennifer ^a   Webb, Tony ^a   West, Sofie ^a   Widaa, Sara ^a   Yates, Andy ^a   Cahill, Daniel P ^c   Louis, David N ^c   Goldstraw, Peter ^d   Nicholson, Andrew G ^d   Brasseur, Francis ^e   Looijenga, Leendert ^f   Weber, Barbara L ^g   Chiew, Yoke Eng ^h   DeFazio, Anna ^h   Greaves, Mel F ⁱ   Green, Anthony R ^j   Campbell, Peter ^a   Birney, Ewan ^b   Easton, Douglas F ^j   Chenevix Trench, Georgia ^k   Tan, Min Han ^l   Khoo, Sok Kean ^l   Teh, Bin Tean ^l   Yuen, Siu Tsan ^m   Leung, Suet Yi ^m   Wooster, Richard ^a   Futreal, P Andrew ^a   Stratton, Michael R ^a,i   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^f JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^l VAN ANDEL RESEARCH INSTITUTE   (United States)

^m UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; DNA; ENZYME; GENE EXPRESSION; GENETIC ANALYSIS; GENOME; MUTATION;

ARTICLE; CANCER; CANCER GENETICS; CARCINOGENESIS; DNA REPAIR; EVOLUTION; EXON; GENE SEQUENCE; GENETIC VARIABILITY; GENOMICS; HUMAN; PRIORITY JOURNAL; SOMATIC MUTATION;

AMINO ACID SEQUENCE; DNA MUTATIONAL ANALYSIS; GENES, NEOPLASM; GENOME, HUMAN; GENOMICS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN KINASES;

EID: 33947101019     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature05610     Document Type: Article

References (39)

1. Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177-183 (2004).
2. Futreal, P. A. et al. Cancer and genomics. Nature 409, 850-852 (2001).
3. Sawyers, C. Targeted cancer therapy. Nature 432, 294-297 (2004).
4. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. & Sudarsanam, S. The protein kinase complement of the human genome. Science 298, 1912-1934 (2002).
5. Stephens, P. et al. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nature Genet. 37, 590-592 (2005).
6. Davies, H. et al. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res. 65, 7591-7595 (2005).
7. Hunter, C. et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Res. 66, 3987-3991 (2006).
8. Bignell, G. et al. Sequence analysis of the protein kinase gene family in human testicular germ-cell tumours of adolescents and adults. Genes Chromosom. Cancer 45, 42-46 (2006).
9. Bardelli, A. et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949 (2003).
10. Wang, T.-L. et al. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc. Natl Acad. Sci. USA 99, 3076-3080 (2002).
11. Lonardi, S., Tosoni, A. & Brandes, A. A. Adjuvant chemotherapy in the treatment of high grade gliomas. Cancer Treat. Rev. 31, 79-89 (2005).
12. Karran, P., Offman, J. & Bignami, M. Human mismatch repair, drug-induced DNA damage, and secondary cancer. Biochimie 85, 1149-1160 (2003).
13. Greenman, C., Wooster, R., Futreal, P. A., Stratton, M. R. & Easton, D. F. Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 173, 2187-2198 (2006).
14. Yang, Z., Ro, S. & Rannala, B. Likelihood models of somatic mutation and codon substitution in cancer genes. Genetics 165, 695-705 (2003).
15. Goldman, N. & Yang, Z. A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol. Biol. Evol. 11, 725-736 (1994).
16. Sanchez-Cespedes, M. et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 62, 3659-3662 (2002).
17. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949-954 (2002).
18. Granzier, H. L. & Labeit, S. Titin and its associated proteins: the third myofilament system of the sarcomere. Adv. Protein Chem. 71, 89-119 (2005).
19. Machado, C. & Andrew, D. J. D-Titin: a giant protein with dual roles in chromosomes and muscles. J. Cell Biol. 151, 639-652 (2000).
20. Machado, C., Sunkel, C. E. & Andrew, D. J. Human autoantibodies reveal Titin as a chromosomal protein. J. Cell Biol. 141, 321-333 (1998).
21. Zastrow, M. S., Flaherty, D. B., Benian, G. M. & Wilson, K. L. Nuclear Titin interacts with A- and B-type lamins in vitro and in vivo. J. Cell Sci. 119, 239-249 (2006).
22. Shiloh, Y.ATMand related protein kinases: safeguarding genome integrity. Nature Rev. Cancer 3, 155-168 (2003).
23. Renwick, A. et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nature Genet. 38, 873-875 (2006).
24. Markowitz, S. et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338 (1995).
25. Howe, J. R. et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nature Genet. 28, 184-187 (2001).
26. Wan, P. T. C. et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116, 855-867 (2004).
27. Irusta, P. M. et al. Definition of an inhibitory juxtamembrane WW-like domain in the platelet-derived growth factor beta receptor. J. Biol. Chem. 277, 38627-38634 (2002).
28. Teng, D. et al. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res. 57, 4177-4182 (1997).
29. Su, G. et al. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res. 58, 2339-2342 (1998).
30. Parsons, D. W. et al. Colorectal cancer Mutations in a signalling pathway. Nature 436, 792 (2005).
31. Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J. & Barr, R. K. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim. Biophys. Acta 1697, 89-101 (2004).
32. Kyriakis, J. M. & Avruch, J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869 (2001).
33. Joshi-Tope, G. et al. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 33, D428-D432 (2005).
34. Mi, H. et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res. 33, D284-D288 (2005).
35. Kushida, T., Takagi, T. & Fukuda, K. Event ontology: a pathway-centric ontology for biological processes. Pac. Symp. Biocomput. 11, 152-163 (2006).
36. Wilkie, A., Patey, S., Kan, S., van den Ouweland, A. & Hamel, B. FGFs, their receptors, and human limb malformations: clinical and molecular correlations. Am. J. Med. Genet. 112, 266-278 (2002).
37. Cappellen, D. et al. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nature Genet. 23, 18-20 (1999).
38. Sjoblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274 (2006).
39. Brose, M. S. et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 62, 6997-7000 (2002).